Skip to main content
Tech.euFundingExplorerBeta

Baron O'Shaughnessy

Investor profile

Angel

Baron O'Shaughnessy has backed 1 European tech company across 1 funding round in 2023, joining rounds totalling €1.8M. Most active in Healthtech. Data as of Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2023
1 yr
Total round €
€1.8M
sum of rounds joined

Deals by year

distinct rounds / year
Baron O'Shaughnessy — deals by year — interactive chart.
Data table
Baron O'Shaughnessy — deals by year
20231

Top sectors

by deals
Baron O'Shaughnessy — top sectors — interactive chart.
Data table
Baron O'Shaughnessy — top sectors
Healthtech1

Stages

by deals
Baron O'Shaughnessy — stages — interactive chart.
Data table
Baron O'Shaughnessy — stages
Pre-Seed1

Countries

by deals
Baron O'Shaughnessy — countries — interactive chart.
Data table
Baron O'Shaughnessy — countries
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Baron O'Shaughnessy — 1 dealsBaron O'ShaughnessyDamien Marmion — 1 shared deals · click to openDamien MarmionDavid Giampaolo — 1 shared deals · click to openDavid GiampaoloFounders Factory — 1 shared deals · click to openFounders FactoryJacob Haddad — 1 shared deals · click to openJacob HaddadNeo Kuma Ventures — 1 shared deals · click to openNeo Kuma VenturesPhil Mohr — 1 shared deals · click to openPhil MohrPlug and Play — 1 shared deals · click to openPlug and PlayPuli Liyanagama — 1 shared deals · click to openPuli LiyanagamaRemus Capital — 1 shared deals · click to openRemus CapitalRoland Rudd — 1 shared deals · click to openRoland RuddStephen Bourke — 1 shared deals · click to openStephen BourkeSyndicateRoom’s Access fund — 1 shared deals · click to openSyndicateRoom’s Access fund

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Syndi HealthUK1€1.8M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Syndi HealthPre-Seed€1.8M2023-02
← Back to investors